Profile picture

Associate Professor Wolfgang Dichtl

Innsbruck Medical University, Innsbruck (Austria)
Membership: FESC Member EHRA Member
Follow
Biography
I fell in love with cardiology in the very beginning of my medical studies. My mission is the vivid combination of treating patients with all kind of cardiovascular diseases and perfoming research, both in the basic science field and in clinical studies. In particular, I try to perfectly perform and further improve treatment options for people with serious conditions such as heart failure, arrhythmias and myocardial infarction. These include cardiac device therapy, ablation and acute PCI. Starting to analyse inflammatory transcription factors in atherosclerosis (PhD in Sweden), I moved to study also aortic stenosis, takotsubo cardiomyopathy, and ICD/CRT optimization. Imaging, intensive care medicine and the "heart-brain axis" are also interests of mine, with a focus on echocardiography, cardiac computed tomography and central sleep apnea
Logo ESC

Contributor content

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6
Journal
Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6
13 April 2026
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Journal
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
15 December 2025
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Journal
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
9 April 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
Journal
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
9 April 2024
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
Journal
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
12 November 2023
Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study
Journal
Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study
6 July 2023
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update
Journal
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update
22 June 2023
Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis
Journal
Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis
6 January 2021
Coexistence and outcome of coronary artery disease in Takotsubo syndrome
Journal
Coexistence and outcome of coronary artery disease in Takotsubo syndrome
2 June 2020
Left ventricular unloading by percutaneous mechanical circulatory support in takotsubo syndrome with severe cardiogenic shock
Journal
Left ventricular unloading by percutaneous mechanical circulatory support in takotsubo syndrome with severe cardiogenic shock
27 May 2019

ESC 365 is supported by